Petrocort Antipruritic Lip 21

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Petrocort Antipruritic Lip 21
Generic name: HYDROCORTISONE
Manufacturer: Clinical Formula LLC
Product type: HUMAN OTC DRUG
SPL set ID: 7d408e08-d777-4dfb-bb5e-b4fe5d6f4c7b
SPL ID: 0c863e4e-1b19-6315-e063-6294a90a9034
Version: 2
Effective date: 2023-12-15
Source export date: 2026-09-28
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/bb1af06e95bcf9567b07e56fcf3a03c0cac3c7c82ff89d4c970881174949e5b7/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 05:44:17

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Petrocort Antipruritic Lip 21	openfda.brand_name
generic name		HYDROCORTISONE	openfda.generic_name
manufacturer name		Clinical Formula LLC	openfda.manufacturer_name
ndc	package	51822-021-15	openfda.package_ndc
ndc	product	51822-021	openfda.product_ndc
ndc11	package	51822002115	derived:openfda.package_ndc
rxcui		310861	openfda.rxcui
spl id		0c863e4e-1b19-6315-e063-6294a90a9034	id
spl set id		7d408e08-d777-4dfb-bb5e-b4fe5d6f4c7b	set_id
unii		WI4X0X7BPJ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS: For external use only. If condition worsens, does not improve, or symptoms persist for more than 7 days or clear up and reoccur again within a few days, discontinue use and consult a physician. Keep from heat. Keep out of reach of children.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.